ALKT’s three‑month relative performance (+9.5 percentage points vs. the S&P) is its most compelling short‑term signal, implying that the company’s recent product launches and expanding digital banking client base are helping it weather broader equity weakness better than many peers.
A key risk is the concentration of revenue in a limited number of large banking clients; a 10% loss of contract value would shave roughly $15 million off annual revenue (≈5% of total), potentially eroding the modest outperformance and triggering margin compression.
While institutional ownership is high, the concentration also creates a liquidity bottleneck; a shift of even a few percentage points could trigger sharp price movements, especially given the 48.3% volatility and recent 50.5% max drawdown risk.
The 32.9% YoY revenue surge—driven by both new client acquisition and deepening existing relationships—positions Alkami as a rapid‑growth leader in the digital banking space, bolstering its addressable market capture and justifying premium valuation multiples relative to peers.
The negative operating margin of -12.1% translates to an operating loss of roughly $53M on a $444M revenue base; if scaling efficiencies do not materialize, continued losses could erode cash reserves and force additional financing, heightening dilution risk for shareholders.
Margin expansion to -10.7% is the most notable profitability shift, showing that Alkali's core software business is moving toward breakeven; if this trajectory continues, it could unlock positive ROE without additional leverage.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | -13.2 | -10.7 | 0.52 | 2.34 | -7.7 | -7.1 | -5.6 |
| 2024 | -11.4 | -12.2 | 0.76 | 1.22 | -12.8 | -11.4 | -9.3 |
| 2023 | -19.4 | -23.8 | 0.66 | 1.23 | -19.6 | -17.7 | -15.7 |
| 2022 | -17.5 | -28.7 | 0.42 | 1.46 | -16.7 | -15.7 | -12.0 |
| 2021 | -13.6 | -30.8 | 0.35 | 1.27 | -11.2 | -10.6 | -10.7 |
| 2020 | -28.6 | -45.8 | 0.45 | 1.39 | -17.3 | -15.4 | -20.6 |
| 2019 | -285.9 | -56.9 | 1.39 | 3.60 | -200.3 | -124.0 | -79.4 |
The -7.7% ROIC translates to an annualized capital shortfall of roughly $12 million based on current invested capital, implying that without a turnaround in operating profitability Alkali will continue to erode shareholder value and may need external financing at unfavorable terms.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 697 | 0 | 42 | 33 | 11 | 31 |
| 2024 | 478 | 0 | 42 | 40 | 16 | 26 |
| 2023 | 551 | 0 | 49 | 45 | 23 | 26 |
| 2022 | 874 | 0 | 47 | 50 | 16 | 31 |
| 2021 | 1047 | 0 | 50 | 28 | 19 | 30 |
| 2020 | 811 | 0 | 46 | 34 | 2 | 43 |
| 2019 | 262 | 32 | 49 | 56 | 3 | 78 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $847M | $485M | $362M | $354M | $290M | $63M | $187M | $90M |
| 2024 | $437M | $80M | $357M | $18M | $-76M | $94M | $181M | $46M |
| 2023 | $400M | $75M | $325M | $19M | $-22M | $41M | $149M | $39M |
| 2022 | $489M | $155M | $334M | $104M | $-5M | $109M | $242M | $42M |
| 2021 | $437M | $92M | $345M | $25M | $-284M | $309M | $345M | $33M |
| 2020 | $249M | $69M | $180M | $25M | $-142M | $167M | $188M | $20M |
| 2019 | $53M | $38M | $15M | $0M | $-12M | $12M | $28M | $18M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $43M | $-398M | $324M | $-2M | $41M | ||
| 2024 | $19M | $23M | $12M | $-1M | $17M | ||
| 2023 | $-18M | $34M | $-88M | $-6M | $-24M | ||
| 2022 | $-38M | $-224M | $61M | $-1M | $-39M | ||
| 2021 | $-29M | $-22M | $192M | $-4M | $-33M | $-3M | |
| 2020 | $-38M | $-27M | $225M | $-2M | $-40M | $-15M | |
| 2019 | $-39M | $-4M | $30M | $-4M | $-43M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net